Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Pediatric Steroid-Dependent/Resistant Nephrotic Syndrome
NCT07003438Phase 1Not yet recruiting
- Start
- Jun 2025
- Primary completion
- Apr 2026
- Modality
- Live Biotherapeutic Products
01
Overview
Phase 1, randomised, open-label trial of Fecal Microbiota Transplantation Capsule in nephrotic syndrome (4 arms). Primary endpoints: 24-hour urinary protein content at 48 weeks, Gut microbiota composition and 1 more. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT07003438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07003438.